Monoclonal Antibody Discovery Platform
Our biologics team has experience developing multiple large molecules, including monoclonal antibodies, bi-specific antibodies and fusion proteins. We use a novel, fully human phage display library and protein engineering techniques to address unique challenges of antibody development. We are currently pursuing multiple large molecules in oncology, immune and fibrotic diseases.